These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23943800)

  • 1. Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer.
    Liu YP; Liao WC; Ger LP; Chen JC; Hsu TI; Lee YC; Chang HT; Chen YC; Jan YH; Lee KH; Zeng YH; Hsiao M; Lu PJ
    Cancer Res; 2013 Oct; 73(20):6194-205. PubMed ID: 23943800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane.
    Maira SM; Galetic I; Brazil DP; Kaech S; Ingley E; Thelen M; Hemmings BA
    Science; 2001 Oct; 294(5541):374-80. PubMed ID: 11598301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient.
    Chen YC; Li HY; Liang JL; Ger LP; Chang HT; Hsiao M; Calkins MJ; Cheng HC; Chuang JH; Lu PJ
    Oncotarget; 2017 May; 8(18):29699-29710. PubMed ID: 27447863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New players in high fat diet-induced obesity: LETM1 and CTMP.
    Park J; Li Y; Kim SH; Yang KJ; Kong G; Shrestha R; Tran Q; Park KA; Jeon J; Hur GM; Lee CH; Kim DH; Park J
    Metabolism; 2014 Mar; 63(3):318-27. PubMed ID: 24333006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxy-terminal modulator protein induces Akt phosphorylation and activation, thereby enhancing antiapoptotic, glycogen synthetic, and glucose uptake pathways.
    Ono H; Sakoda H; Fujishiro M; Anai M; Kushiyama A; Fukushima Y; Katagiri H; Ogihara T; Oka Y; Kamata H; Horike N; Uchijima Y; Kurihara H; Asano T
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1576-85. PubMed ID: 17615157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice.
    Shin JY; Chung YS; Kang B; Jiang HL; Yu DY; Han K; Chae C; Moon JH; Jang G; Cho MH
    Cancer Gene Ther; 2013 Mar; 20(3):186-94. PubMed ID: 23392203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T; Luoh SW
    Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
    Schick V; Majores M; Engels G; Spitoni S; Koch A; Elger CE; Simon M; Knobbe C; Blümcke I; Becker AJ
    Acta Neuropathol; 2006 Dec; 112(6):715-25. PubMed ID: 17013611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
    Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
    Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
    Liu X; Yang Q; Zhu LH; Liu J; Deng KQ; Zhu XY; Liu Y; Gong J; Zhang P; Li S; Xia H; She ZG
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxyl-terminal modulator protein induces apoptosis by regulating mitochondrial function in lung cancer cells.
    Hwang SK; Minai-Tehrani A; Yu KN; Chang SH; Kim JE; Lee KH; Park J; Beck GR; Cho MH
    Int J Oncol; 2012 May; 40(5):1515-24. PubMed ID: 22200884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.
    Simon PO; McDunn JE; Kashiwagi H; Chang K; Goedegebuure PS; Hotchkiss RS; Hawkins WG
    Int J Cancer; 2009 Aug; 125(4):942-51. PubMed ID: 19405118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxy-Terminal Modulator Protein (CTMP) is a mitochondrial protein that sensitizes cells to apoptosis.
    Parcellier A; Tintignac LA; Zhuravleva E; Cron P; Schenk S; Bozulic L; Hemmings BA
    Cell Signal; 2009 Apr; 21(4):639-50. PubMed ID: 19168129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain.
    Yu J; Henske EP
    Cancer Res; 2006 Oct; 66(19):9461-6. PubMed ID: 17018601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentivirus-mediated carboxyl-terminal modulator protein gene transfection via aerosol in lungs of K-ras null mice.
    Hwang SK; Kwon JT; Park SJ; Chang SH; Lee ES; Chung YS; Beck GR; Lee KH; Piao L; Park J; Cho MH
    Gene Ther; 2007 Dec; 14(24):1721-30. PubMed ID: 17960162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxyl-terminal modulator protein regulates Akt signaling during skeletal muscle atrophy in vitro and a mouse model of amyotrophic lateral sclerosis.
    Wang J; Fry CME; Walker CL
    Sci Rep; 2019 Mar; 9(1):3920. PubMed ID: 30850672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas.
    Knobbe CB; Reifenberger J; Blaschke B; Reifenberger G
    J Natl Cancer Inst; 2004 Mar; 96(6):483-6. PubMed ID: 15026474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.